Home › Attention Deficit Hyperactivity Disorder › Washington
Attention Deficit Hyperactivity Disorder clinical trials in Washington
7 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Washington.
Cities in Washington
The Myelin Disorders Biorepository Project
- Seattle Children's Hospital, Seattle
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT03047369Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Everett
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 6, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Everett
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 6, 2026 · NCT07717892A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- Core Clinical Research, Everett
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07759154A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Alkermes Investigational Site, Bellevue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07755410Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Aug 19, 2026 · NCT05776056Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
- Seattle Children's Hospital, Seattle
- Seattle Children's Hospital, Seattle
Recruiting
Ages 13 to 17 · All sexes · Updated Dec 15, 2025 · NCT07281092From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.